Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis-Reference-Cited by-同舟云学术

Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis

Published:2019-02-10 Issue:4 Volume:39 Page:705-713
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Reverter Enric¹²^ORCID,Lozano Juan J.²,Alonso Cristina³,Berzigotti Annalisa¹²,Seijo Susana¹²,Turon Fanny¹²,Baiges Anna¹²,Martínez‐Chantar Mari L.²⁴,Mato José M.²⁴,Martínez‐Arranz Ibon³,La Mura Vincenzo¹²^ORCID,Hernández‐Gea Virginia¹²,Bosch Jaume¹²,García‐Pagán Juan C.¹²^ORCID

Affiliation:

1. Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital ClínicInstitut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona Barcelona Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) Barcelona Spain

3. OWL Metabolomics Parque Tecnológico de Bizkaia BizkaiaSpain

4. CIC bioGUNE Parque Tecnológico de Bizkaia BizkaiaSpain

Funder

Ministerio de Ciencia e Innovación

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14042